| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 5, 2025 | SHC Sotera Health Co | Gtcr Investment XI LLC74 | Director, 10% Owner | Sell | 8,000,000 | $15.11 | $120,888,000.00 | -16.3% | +6.0% | - | |
| Sep 5, 2025 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chairman &CEO | Sell | 400 | $500.50 | $200,201.00 | -0.1% | +16.8% | - | |
| Sep 4, 2025 | VCYT Veracyte, Inc. | Stapley Marc60 | Chief Executive Officer | Sell | 7,667 | $30.41 | $233,132.77 | -2.2% | +51.5% | - | |
| Sep 3, 2025 | FLGT Fulgent Genetics, Inc. | Gao Hanlin73 | Chief Scientific Officer | Sell | 1,063 | $22.03 | $23,414.38 | -0.1% | +29.0% | - | |
| Sep 3, 2025 | FLGT Fulgent Genetics, Inc. | Xie Jian77 | President And COO | Sell | 1,128 | $22.03 | $24,846.12 | -0.3% | +29.0% | - | |
| Sep 3, 2025 | MEDP Medpace Holdings, Inc. | Burwig Susan E64 | Exec. VP, Operations | Sell | 10,000 | $480.00 | $4,800,000.00 | -14.8% | +21.3% | - | |
| Sep 2, 2025 | NTRA Natera, Inc. | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 3,000 | $166.62 | $499,864.74 | -0.8% | +38.3% | - | |
| Sep 2, 2025 | NOTV Inotiv, Inc. | Neff R Matthew92 | Director | Sell | 2,000 | $1.67 | $3,337.60 | -1.3% | -44.9% | - | |
| Sep 2, 2025 | GH Guardant Health, Inc. | Joyce Meghan V.56 | Director | Sell | 100 | $65.84 | $6,584.00 | -0.9% | +58.2% | - | |
| Sep 2, 2025 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 1,339 | $23.93 | $32,042.27 | -2.0% | +61.6% | - | |
| Sep 2, 2025 | XGN Exagen Inc. | Black Jeffrey G.75 | Chief Financial Officer | Sell | 20,466 | $9.79 | $200,362.14 | -7.1% | -22.0% | - | |
| Sep 2, 2025 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 5,079 | $166.53 | $845,795.04 | -1.0% | +38.3% | - | |
| Sep 2, 2025 | A Agilent Technologies, Inc. | McDonnell Padraig71 | President And CEO | Sell | 2,000 | $124.88 | $249,760.00 | -5.6% | +19.9% | - | |
| Sep 2, 2025 | WGS Genedx Holdings Corp. | Feeley Kevin46 | Chief Financial Officer | Sell | 378 | $125.81 | $47,556.03 | -8.4% | +27.6% | - | |
| Sep 2, 2025 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 37,393 | $475.87 | $17,794,383.07 | -2.0% | +24.2% | - | |
| Aug 29, 2025 | BDSX Biodesix Inc | Schuler Jack W45 | - | Buy | 3,488,372 | $0.43 | $1,499,999.96 | +16.7% | -3.0% | - | |
| Aug 29, 2025 | TMO Thermo Fisher Scientific Inc. | Holmes Joseph R. | VP &Chief Accounting Officer | Sell | 385 | $492.63 | $189,661.91 | -7.3% | +19.9% | - | |
| Aug 28, 2025 | NTRA Natera, Inc. | Chapman Rowan E52 | Director | Sell | 2,750 | $166.99 | $459,222.50 | -31.4% | +41.2% | - | |
| Aug 27, 2025 | RVTY Revvity, Inc. | Michas Alexis P68 | Director | Sell | 500 | $89.01 | $44,505.00 | -6.4% | +19.2% | - | |
| Aug 27, 2025 | FLGT Fulgent Genetics, Inc. | Gao Hanlin73 | Chief Scientific Officer | Sell | 943 | $21.48 | $20,260.07 | - | +42.6% | - | |
| Aug 27, 2025 | CSTL Castle Biosciences Inc | Oelschlager Kristen M72 | Chief Operating Officer | Sell | 18,007 | $21.69 | $390,571.83 | -10.5% | +79.2% | - | |
| Aug 27, 2025 | RDNT Radnet, Inc. | Hames Norman R56 | Pres And Coo-west Operations | Sell | 5,000 | $71.10 | $355,500.00 | -20.1% | +16.3% | - | |
| Aug 27, 2025 | CSTL Castle Biosciences Inc | Oelschlager Kristen M72 | Chief Operating Officer | Sell | 12,677 | $22.02 | $279,134.86 | -8.2% | +79.2% | - | |
| Aug 27, 2025 | WGS Genedx Holdings Corp. | Ryan Jason65 | Director | Sell | 39,222 | $127.37 | $4,995,800.61 | -5.2% | +29.7% | - | |
| Aug 27, 2025 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 620 | $475.00 | $294,500.00 | - | +29.2% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.